| 1 Clinical cure rate at the end of therapy |
2 |
177 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.82, 1.34] |
| 2 Clinical cure rate during therapy |
1 |
63 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.17 [1.01, 1.37] |
| 3 Clinical cure rate at post‐treatment |
1 |
95 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.85, 1.03] |
| 4 AOM complications: Recurrent AOM after completion of therapy |
1 |
100 |
Risk Ratio (M‐H, Random, 95% CI) |
4.16 [0.48, 35.95] |
| 5 Specific adverse reactions to medication: Diarrhoea |
1 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.0 [0.06, 15.59] |
| 6 Specific adverse reactions to medication: Skin adverse events |
1 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.0 [0.21, 4.74] |
| 7 Compliance rate |
1 |
67 |
Risk Ratio (M‐H, Random, 95% CI) |
1.0 [0.94, 1.06] |
